Zurueck zur Suche

Reporte zur Charge 3SN5B

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KY 1

VAERS 2640684

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 3SN5B

moderat
Staat
-
Alter
73,0
Geschlecht
M
Eingang
22.01.2021
Impfdatum
-
Beginn
22.01.2020
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chills Tremor

Symptomtext

chills and shaking Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1188617

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 3SN5B

gering
Staat
KY
Alter
11,0
Geschlecht
M
Eingang
10.04.2021
Impfdatum
07.12.2020
Beginn
07.12.2020
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

product dispensing error; product administration error; Expired dose of Boostrix; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 11-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 3SN5B, expiry date 4th December 2020) for prophylaxis. Concurrent medical conditions included asthma. On 7th December 2020, the patient received Boostrix. On 7th December 2020, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the patient experienced product dispensing error and product administration error. On an unknown date, the outcome of the expired vaccine used, product dispensing error and product administration error were unknown. Follow up information received from a nurse on 2nd April 2021: The patient's demographic details were updated. The patient had current condition of asthma and had NKA (No known Allergies). The patient received Boostrix that expired 3 days prior to the administration of vaccine. As per reporter, error occurred in dispensing and administration, which led to product dispensing error and product administration error. The reporter was unsure why error occurred. There were no adverse effects from this event. As per medical director's recommendations, the patient's parent was advised to consult physician if any injury due to unknown efficacy of the expiration date. The VAERS details updated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Asthma
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-